Diet drug Qnexa will get a second look - latimes.com

Qnexa : Videos

QNEXA, a New Weight Loss Drug, Reviewed by FDA QNEXA, a New Weight Loss Drug, Reviewed by FDA In this video news segment, Dr. Karon LoCicero, LMG Medical Director, discusses the new weight loss medication, Qnexa. Rated: -1     Duration: 188 seconds     Video type: YouTube     Hosted by: www.youtube.com on Fri, 16 Jul 2010 09:32:18 PDT	QNEXA Review - Dietspotlight.com QNEXA Review - Dietspotlight.com dietspotlight.com begins its review of Qnexa by noting that when it comes to weight loss products and dieting pills, many of these products come ... Rated: -1     Duration: 102 seconds     Video type: YouTube     Hosted by: www.youtube.com on Wed, 07 Sep 2011 03:41:41 PDT	Drugs for Obesity; Weight-loss drug QNEXA gets thumbs-down from FDA panel Drugs for Obesity; Weight-loss drug QNEXA gets thumbs-down from FDA panel New Drugs for obesity Old phenteramine like Subutramine Meridia 5-10 lb wt loss Ally, Orlistat Xenical 5-15 lb wt loss Marijuana, THC The Munchies ... Rated: 5     Duration: 207 seconds     Video type: YouTube     Hosted by: www.youtube.com on Wed, 14 Jul 2010 06:23:28 PDT	Vivuss QNEXA - FDA Panel Analysis Vivuss QNEXA - FDA Panel Analysis For new drugs, see healthlifeandstuff.com - An analysis of what might happen with the drug Qnexa from Vivus as it goes up for an FDA review panel Rated: 5     Duration: 363 seconds     Video type: YouTube     Hosted by: www.youtube.com on Mon, 12 Jul 2010 11:34:52 PDT
Vivus Adds 12% in Early Trading on QNEXA Study Results Vivus Adds 12% in Early Trading on QNEXA Study Results Vivus (VVUS) is up by double digits in early trading, after it says long-term data demonstrated patients treated with the investigational drug ... Rated: -1     Duration: 31 seconds     Video type: YouTube     Hosted by: www.youtube.com on Mon, 04 Apr 2011 08:55:06 PDT	Vivus Jumps 13% After Positive Research Report on QNEXA (VVUS) Vivus Jumps 13% After Positive Research Report on QNEXA (VVUS) Vivus Inc's (NASDAQ:VVUS) share price jumped after research showed its experimental diet pill Qnexa also helped lower blood pressure and ... Rated: -1     Duration: 73 seconds     Video type: YouTube     Hosted by: www.youtube.com on Mon, 04 Apr 2011 10:41:57 PDT	QNEXA - Why the FDA Panel Voted No QNEXA - Why the FDA Panel Voted No Why did the FDA advisory panel vote against Vivus's Qnexa for treating obesity? Rated: -1     Duration: 295 seconds     Video type: YouTube     Hosted by: www.youtube.com on Thu, 22 Jul 2010 05:37:55 PDT	Mr. & Mrs. CHOI clip#16 - the sweetest couple of KPOP Mr. & Mrs. CHOI clip#16 - the sweetest couple of KPOP holds it and slightly pulled her until they stopped when people gathered around them - Qnexa They really know what's the real score between ... Rated: 4.8545456     Duration: 149 seconds     Video type: YouTube     Hosted by: www.youtube.com on Tue, 13 Sep 2011 17:53:58 PDT
Mr. & Mrs. CHOI clip#15 - i dont need another woman Mr. & Mrs. CHOI clip#15 - i dont need another woman is always the (first) one to be hugged by Siwon unlike others. (Qnexa). keke especial thanks to Qnexa for giving this link :) SOOWON fighting ... Rated: 4.8666668     Duration: 121 seconds     Video type: YouTube     Hosted by: www.youtube.com on Fri, 09 Sep 2011 15:38:01 PDT	New Blockbuster Weight Loss Drugs: QNEXA, Contrave & Empatic New Blockbuster Weight Loss Drugs: QNEXA, Contrave & Empatic Thin-site = weight loss demystified. Obesity expert Dr. David Edelson explains the little-known secrets that medical pros know, and that you ... Rated: -1     Duration: 181 seconds     Video type: YouTube     Hosted by: www.youtube.com on Mon, 19 Oct 2009 09:58:12 PDT	Vivus Jumps 22% As Investors Rally Behind Confidence In "Efficacy And Safety" Of QNEXA Vivus Jumps 22% As Investors Rally Behind Confidence In "Efficacy And Safety" Of QNEXA "The FDA rejected Vivus' (NASDAQ:VVUS) obesity drug Qnexa, however, shares of Vivus are trading 21.7% higher in premarket action as ... Rated: 5     Duration: 60 seconds     Video type: YouTube     Hosted by: www.youtube.com on Fri, 29 Oct 2010 05:58:48 PDT	Mr. & Mrs. CHOI clip#17 - the infamous hug in GDA 2010 Mr. & Mrs. CHOI clip#17 - the infamous hug in GDA 2010 i've been searching this moment for so long but Qnexa(1 of the guardians) found it. lol Sooyoung rubs the back of Siwon after they hugging ... Rated: 4.8666668     Duration: 106 seconds     Video type: YouTube     Hosted by: www.youtube.com on Sun, 25 Sep 2011 17:51:06 PDT
World Hip Hop Champs - Hopskotch Showing World Hip Hop Champs - Hopskotch Showing NZ crew hopskotch chowing their worlds routine before heading over to the world hip hop champs in Las Vegas. ... hiphop skotch ... "world hip ... Rated: 4.4285712     Duration: 128 seconds     Video type: YouTube     Hosted by: www.youtube.com on Tue, 06 Sep 2011 20:42:06 PDT	News Update: Vivus Halted in Pre-Market Trade - FDA Panel to Consider QNEXA Diet Drug Today News Update: Vivus Halted in Pre-Market Trade - FDA Panel to Consider QNEXA Diet Drug Today Vivus (VVUS) is halted in US pre-market trade as an FDA advisory panel today weighs the safety risks and benefits of the company's diet drug ... Rated: 5     Duration: 27 seconds     Video type: YouTube     Hosted by: www.youtube.com on Thu, 15 Jul 2010 06:20:05 PDT	Sammy squeaks! Sammy squeaks! speak Eagle. ... the little poker face ... "Newt Gingrich" "Mitt Romney" "Jennifer Hudson" Qnexa "Express ... Rated: -1     Duration: 66 seconds     Video type: YouTube     Hosted by: www.youtube.com on Mon, 09 Jan 2012 11:30:16 PST	The FDA Issues Health Advisory For Drug Topiramate (VVUS,JNJ) The FDA Issues Health Advisory For Drug Topiramate (VVUS,JNJ) a health advisory for one of the compounds in Vivus Inc's (NASDAQ:VVUS) diet drug Qnexa. The FDA warned that pregnant women who consume the ... Rated: -1     Duration: 63 seconds     Video type: YouTube     Hosted by: www.youtube.com on Fri, 04 Mar 2011 12:42:24 PST
Vivus Said Its Effort To Win Regulatory Approval For Weight Loss Pill May Be Helped By Study Vivus Said Its Effort To Win Regulatory Approval For Weight Loss Pill May Be Helped By Study (NASDAQ:VVUS) said its effort to win regulatory approval for its weight-loss pill Qnexa may be helped by a study showing little risk of birth ... Rated: -1     Duration: 36 seconds     Video type: YouTube     Hosted by: www.youtube.com on Wed, 18 May 2011 07:59:41 PDT	Phentermine plus Topamax causes woman to lose 55 lbs, man 73 lbs Phentermine plus Topamax causes woman to lose 55 lbs, man 73 lbs Hi, this is Larry Hobbs @ FatNew.com. This video clip talks about the diet drug Qnexa, which is Phentermine plus Topamax (topiramate), Contrave ... Rated: 5     Duration: 476 seconds     Video type: YouTube     Hosted by: www.youtube.com on Tue, 13 Apr 2010 12:20:21 PDT	News Update: Vivus Shares Jump 10% On Positive Obesity Drug Test Results News Update: Vivus Shares Jump 10% On Positive Obesity Drug Test Results erectile dysfunction reported positive top-line results from a two-year study of its Qnexa controlled release capsules, which is an ... Rated: -1     Duration: 62 seconds     Video type: YouTube     Hosted by: www.youtube.com on Tue, 21 Sep 2010 07:30:57 PDT	VIVUS and Carnival Corporation are Among the Companies With Heavy Call Option Volume VIVUS and Carnival Corporation are Among the Companies With Heavy Call Option Volume around 18 times their average volume, on news that the company will resubmit its drug Qnexa for FDA approval. Carnival Corporation (NYSE:CCL ... Rated: -1     Duration: 94 seconds     Video type: YouTube     Hosted by: www.youtube.com on Thu, 15 Sep 2011 11:59:53 PDT
Health Buzz Episode 2 Health Buzz Episode 2 why we're shaming Carl's Jr.'s foot-long cheeseburger and why the FDA nixed Qnexa. ... diet sinreview ... Qnexa fda "carl's ... Rated: 5     Duration: 173 seconds     Video type: YouTube     Hosted by: www.youtube.com on Mon, 02 Aug 2010 17:57:48 PDT	Morning Market Snapshot: October 29th, 2010 Morning Market Snapshot: October 29th, 2010 from the FDA regarding its New Drug Application for the investigational new drug Qnexa. The FDA issued the CRL to communicate its decision that ... Rated: 5     Duration: 68 seconds     Video type: YouTube     Hosted by: www.youtube.com on Fri, 29 Oct 2010 05:09:46 PDT	Health Care Sector Report: July 16, 2010 Health Care Sector Report: July 16, 2010 (VVUS) is plunging in morning trade after an FDA panel voted against its diet pill, Qnexa, due to concerns about serious side effects. Meanwhile ... Rated: 5     Duration: 49 seconds     Video type: YouTube     Hosted by: www.youtube.com on Fri, 16 Jul 2010 12:07:50 PDT	BeakerBeat - 06-12-09 BeakerBeat - 06-12-09 ... Beaker Admin ... BeakerBeat "Al Mann" GSK Pfizer "James Douglas" Lorcaserin Qnexa "andrew Bodnar" GLP-1 ... Rated: -1     Duration: 390 seconds     Video type: YouTube     Hosted by: www.youtube.com on Sun, 14 Jun 2009 16:59:24 PDT
FDA weighs pros and cons of QNEXA FDA weighs pros and cons of QNEXA Hosted by: CBS News	QNEXA QNEXA Duration: 76000 seconds Hosted by: CNBC	FDA to Meet This Week on Vivus Obesity Drug QNEXA FDA to Meet This Week on Vivus Obesity Drug QNEXA Duration: 76000 seconds Hosted by: CNBCHosted by: MarketNewsVideo	CNBC Originals: One Nation, Overweight - Watch the full episode now. CNBC Originals: One Nation, Overweight - Watch the full episode now. Duration: 2604000 seconds Hosted by: Hulu
FDA to Meet This Week on Vivus Obesity Drug QNEXA FDA to Meet This Week on Vivus Obesity Drug QNEXA Duration: 2604000 seconds Hosted by: HuluHosted by: Forbes	QNEXA Diet Pill: Lose Weight and Improve Health? QNEXA Diet Pill: Lose Weight and Improve Health? Duration: 2604000 seconds Hosted by: HuluHosted by: ForbesHosted by: oneindia videos	QNEXA, a New Weight Loss Drug, Reviewed by FDA QNEXA, a New Weight Loss Drug, Reviewed by FDA Duration: 2604000 seconds Hosted by: HuluHosted by: ForbesHosted by: oneindia videosHosted by: YouTube	Weight Loss Pill Promises Dramatic Results Weight Loss Pill Promises Dramatic Results Duration: 100000 seconds Hosted by: Bing Video
QNEXA, Experimental Diet Drug, Keeps Weight Off For 2 Years: Study QNEXA, Experimental Diet Drug, Keeps Weight Off For 2 Years: Study Duration: 100000 seconds Hosted by: Bing VideoHosted by: HUFFPOST AolNews	FDA Reviews New Diet Drugs FDA Reviews New Diet Drugs Duration: 205000 seconds Hosted by: ABC News	Vivus Soars on Obesity Trial News Vivus Soars on Obesity Trial News Duration: 205000 seconds Hosted by: ABC NewsHosted by: MarketNewsVideo	Scott Kahan - Fox - Medications Scott Kahan - Fox - Medications Duration: 267000 seconds Hosted by: vimeo
Vivuss QNEXA - FDA Panel Analysis Vivuss QNEXA - FDA Panel Analysis Duration: 267000 seconds Hosted by: vimeoHosted by: YouTube	大学生求职需谨防传销陷阱 大学生求职需谨防传销陷阱 Duration: 72000 seconds Hosted by: ku6	FDA Obesity Drug: Update FDA Obesity Drug: Update Duration: 72000 seconds Hosted by: ku6Hosted by: redOrbit	汽车空调结构与工作原理7112 汽车空调结构与工作原理7112 Duration: 105000 seconds Hosted by: Ku6
New Blockbuster Weight Loss Drugs: QNEXA, Contrave & Empatic New Blockbuster Weight Loss Drugs: QNEXA, Contrave & Empatic Duration: 181000 seconds Hosted by: YouTube	FDA Rejection of QNEXA Threatens Other Diet Drugs FDA Rejection of QNEXA Threatens Other Diet Drugs Duration: 157000 seconds Hosted by: Metacafe	Vivus CEO on Weight Loss Drug Vivus CEO on Weight Loss Drug Duration: 157000 seconds Hosted by: MetacafeHosted by: FOX Business	Phentermine plus Topamax causes woman to lose 55 lbs, man 73 lbs Phentermine plus Topamax causes woman to lose 55 lbs, man 73 lbs Duration: 476000 seconds Hosted by: YouTube
Phentermine plus Topamax causes woman to lose 55 lbs, man... Phentermine plus Topamax causes woman to lose 55 lbs, man... Duration: 476000 seconds Hosted by: YouTubeHosted by: VIDEOSURF	QNEXA Diet Pill: Lose Weight and Improve Health? QNEXA Diet Pill: Lose Weight and Improve Health? Duration: 160000 seconds Hosted by: Metacafe	Drugs for Obesity; Weight-loss drug QNEXA gets thumbs-down from ... Drugs for Obesity; Weight-loss drug QNEXA gets thumbs-down from ... Duration: 207000 seconds Hosted by: YouTube	QNEXA - Why the FDA Panel Voted No QNEXA - Why the FDA Panel Voted No Duration: 207000 seconds Hosted by: YouTubeHosted by: YouTube

Qnexa : Photo Gallery

QNEXA « The Department of Pharmacology & Toxicology – Michigan ... QNEXA « The Department of Pharmacology & Toxicology – Michigan ... Qnexa image. Qnexa	Vivus Presents QNEXA For Obesity Treatment Vivus Presents QNEXA For Obesity Treatment Qnexa for obesity treatment	Whither QNEXA? A Brief History of Diet Pills and the FDA ... Whither QNEXA? A Brief History of Diet Pills and the FDA ... for the diet drug Qnexa?	QNEXA: A magic diet pill? | MNN - Mother Nature Network QNEXA: A magic diet pill? | MNN - Mother Nature Network Qnexa
FDA panel backs previously rejected Vivus obesity pill - USATODAY. FDA panel backs previously rejected Vivus obesity pill - USATODAY. Qnexa is a combination of two	FDA weighs pros and cons of QNEXA - CBS News Video FDA weighs pros and cons of QNEXA - CBS News Video pros and cons of Qnexa	New weight-loss drug QNEXA to get second look by FDA today | MLive. New weight-loss drug QNEXA to get second look by FDA today | MLive. Qnexa.jpg	FDA Panel Recommends Approval of Diet Drug QNEXA - Health News ... FDA Panel Recommends Approval of Diet Drug QNEXA - Health News ... weight loss drug Qnexa,
FDA panel backs diet pill QNEXA - Video on msnbc. FDA panel backs diet pill QNEXA - Video on msnbc. a panel of experts for the fda recommended a new diet drug called Qnexa	QNEXA FDA Approval QNEXA FDA Approval Qnexa is a combination of two	The QNEXA Question - CNBC The QNEXA Question - CNBC Qnexa	Weighing Options | Cover Story | Chemical & Engineering News Weighing Options | Cover Story | Chemical & Engineering News Vivus plans to report data
Vivus Weight-Loss Pill Wins FDA Panel Backing - Bloomberg Vivus Weight-Loss Pill Wins FDA Panel Backing - Bloomberg Vivus Weight-Loss Pill Qnexa	Diet Drug QNEXA: FDA to Reconsider Safety Concerns | Healthland ... Diet Drug QNEXA: FDA to Reconsider Safety Concerns | Healthland ... Diet Drug Qnexa: FDA to	ht_QNEXA_capsules_pills_thg_ ... ht_QNEXA_capsules_pills_thg_ ... Qnexa, seen from the Vivus	QNEXA | Find the Latest News and Tips on QNEXA, Health & Fitness QNEXA | Find the Latest News and Tips on QNEXA, Health & Fitness Qnexa FDA Approval
Vivus Presents QNEXA For Obesity Treatment Vivus Presents QNEXA For Obesity Treatment	Review of Weight loss Drugs : QNEXA, Contrave, Lorcaserin, Sibutramine ... Review of Weight loss Drugs : QNEXA, Contrave, Lorcaserin, Sibutramine ...	QNEXA: Vivus Obesity Drug Not FDA Approved QNEXA: Vivus Obesity Drug Not FDA Approved	New Obesity Drug QNEXA Showed Positive Results In Late Stage Trials ... New Obesity Drug QNEXA Showed Positive Results In Late Stage Trials ...
Another Weight Loss Drug Rejected QNEXA – Shane Weight Loss Camps ... Another Weight Loss Drug Rejected QNEXA – Shane Weight Loss Camps ...	QNEXA Obesity Drug Rejected by F.D.A. Panel QNEXA Obesity Drug Rejected by F.D.A. Panel	QNEXA Reviews – Does QNEXA Work? – Side Effects of QNEXA Revealed QNEXA Reviews – Does QNEXA Work? – Side Effects of QNEXA Revealed	QNEXA can help reduce sleep apnea | Shift Work Disorder News QNEXA can help reduce sleep apnea | Shift Work Disorder News
... Concerns May Sink Both Vivus and Its Obesity Drug QNEXA - CBS News ... Concerns May Sink Both Vivus and Its Obesity Drug QNEXA - CBS News	The QNEXA Question - CNBC The QNEXA Question - CNBC	People taking the diet drug QNEXA as part of a study lost about 10% of ... People taking the diet drug QNEXA as part of a study lost about 10% of ...	QNEXA Review - Learn The TRUTH About QNEXA - Unbiased Consumer Reviews ... QNEXA Review - Learn The TRUTH About QNEXA - Unbiased Consumer Reviews ...
on diet pill QNEXA from Vivus and the weight loss results. The QNEXA ... on diet pill QNEXA from Vivus and the weight loss results. The QNEXA ...	Whither QNEXA? A Brief History of Diet Pills and the FDA | Healthland ... Whither QNEXA? A Brief History of Diet Pills and the FDA | Healthland ...	QNEXA Vs. Phentermine- Which Diet Pill is Better? QNEXA Vs. Phentermine- Which Diet Pill is Better?	QNEXA can help reduce sleep apnea | Shift Work Disorder News QNEXA can help reduce sleep apnea | Shift Work Disorder News
DIETER DIETER DIETER	FDA advisors endorse weight-loss drug QNEXA FDA advisors endorse weight-loss drug QNEXA In a reversal, an FDA advisory committee backs the weight-loss drug Qnexa despite health risks after its maker, Vivus, promises strict oversight. By Shari Roan, Los Angeles Times A panel of medical experts voted overwhelmingly Wednesday to endorse the ...	FDA weighs fate of QNEXA for weight loss, again FDA weighs fate of QNEXA for weight loss, again 21 (HealthDay News) -- The US Food and Drug Administration plans to take a second look at the weight loss pill Qnexa on Wednesday, after initially rejecting it because of concerns about heart problems and possible birth defects.	US to Review Diet Treatment Once Rejected US to Review Diet Treatment Once Rejected The FDA rejected the drug under review, Qnexa, in 2010, amid safety concerns, and the drug's manufacturer is now presenting additional data to argue its case. But thousands of people here in central California, where Qnexa's inventor ran a weight-loss ...
Panel Backs Approval for Obesity Pill Panel Backs Approval for Obesity Pill SILVER SPRING, Md. (AP) - A panel of advisers to the Food and Drug Administration overwhelmingly backed approval for a highly anticipated anti-obesity pill called Qnexa, a drug which the FDA previously rejected due to safety concerns.	US advisers back experimental obesity pill US advisers back experimental obesity pill By Anna Yukhananov, Reuters Experimental obesity drug Qnexa won the backing of US health advisors on Wednesday, raising hopes for approval of the first prescription weight-loss pill in 13 years. Vivus Inc's Qnexa was one of three promising obesity ...	Study: Colonoscopies prevent deaths Study: Colonoscopies prevent deaths LOS ANGELES — A panel of medical experts voted overwhelmingly Wednesday to endorse the controversial weight-loss drug Qnexa, clearing the way for the Food and Drug Administration (FDA) to approve a new prescription obesity medication for the first ...	HP shares fall, Vivus skyrockets in after hours HP shares fall, Vivus skyrockets in after hours based biopharmaceutical company said a US Food and Drug Administration advisory panel recommended in a 20-to-2 vote that the agency approve its weight-loss treatment Qnexa. The shares came off the trading halt and surged 97% to $20.83 in heavy volume.
Climate Scientist Admits To Lying, Leaking Documents Climate Scientist Admits To Lying, Leaking Documents In a reversal, a panel of experts is advising the Food and Drug Administration to approve Qnexa, a weight-loss pill, that was rejected in 2010. The potential benefits for overweight people exceed the risks, such as birth defects and increased heart ...	US HOT STOCKS: Vivus, Orexigen, Arena Active In Late Trading US HOT STOCKS: Vivus, Orexigen, Arena Active In Late Trading Among the companies whose shares are actively trading after hours are Vivus Inc.'s (VVUS), Orexigen Therapeutics (OREX) and Arena Pharmaceuticals Inc. (ARNA) A federal advisory panel on Wednesday overwhelmingly backed Vivus's weight-loss drug Qnexa, ...	After-market Movers For Feb. 22 (VVUS, QCOR, PPO, AWAY, LTD) After-market Movers For Feb. 22 (VVUS, QCOR, PPO, AWAY, LTD) (RTTNews) - Shares of VIVUS, Inc. (VVUS: News ) jumped more than 98% in after hours trading after the drug developer said that an advisory panel of the US Food and Drug Administration has recommended Qnexa be granted marketing approval by the FDA for ...	FDA Advisory Panel Approves Diet Drug FDA Advisory Panel Approves Diet Drug An FDA advisory panel voted 20 to 2 in favor of recommending approval of the weight-loss drug Qnexa. The panel's decision boosts the chances that US regulators could approve a new prescription-weight loss drug for the first time in more than a decade.
Diet Drug QNEXA Being Reconsidered Diet Drug QNEXA Being Reconsidered Next week, the pill Qnexa will be reconsidered by advisors to the Food and Drug Administration. It's a combination of two drugs that individually are FDA-approved. “One which is an anticonvulsant and the other one which is an amphetamine.	High Court Punts On California Medicaid Ruling High Court Punts On California Medicaid Ruling In a reversal, a panel of experts is advising the Food and Drug Administration to approve Qnexa, a weight-loss pill, that was rejected in 2010. The potential benefits for overweight people exceed the risks, such as birth defects and increased heart ...	Drug with Los Osos link to get second FDA review Drug with Los Osos link to get second FDA review The FDA rejected the drug under review, Qnexa, in 2010, amid safety concerns, and the drug's manufacturer is now presenting additional data to argue its case. But thousands of people in San Luis Obispo County, where Qnexa's inventor ran a weight-loss ...	FDA Panel Backs Previously Rejected Obesity Pill FDA Panel Backs Previously Rejected Obesity Pill The FDA panel of outside physicians voted 20-2 in favor of the weight loss drug Qnexa, setting the stage for a potential comeback for a drug that has been plagued by side effects since it was first submitted to the agency in 2010.
Fast Money Opportunity but Only if You're Nimble Fast Money Opportunity but Only if You're Nimble Qnexa, which combines the appetite suppressant phentermine and anti-seizure drug topiramate, helped patients lose at least 10 percent of their weight after a year of treatment, the company said. The FDA has not approved a new obesity drug since 1999.

Qnexa : Latest News, Information, Answers and Websites

FDA Panel Recommends QNEXA For Approval

ROCKVILLE, Md (CBS) - An advisory panel to the FDA has just overwhelming approved a diet pill called Qnexa. Safety concerns have derailed it in the past, but new data obviously changed some minds. Mariel Rrosenwasser tried every diet but could not lose ...

Panel to ponder fate of QNEXA weight-loss pill - CBS News

Once rejected by the FDA over safety concerns, the weight loss pill Qnexa on Wednesday will get a second chance before an FDA advisory committee. Will the ...

Obesity

Qnexa® (phentermine and topiramate) Extended-release Capsules is an investigational, once-per-day, weight-loss therapy that combines low doses of two ...

F.D.A. Still Wary of Diet Pill’s Side Effects

The Food and Drug Administration continues to have concerns that a weight-loss drug it is reviewing for the second time can cause birth defects and heart problems, documents released by the agency on Friday show . The drug, called Qnexa, was rejected by the agency in 2010, largely because of those risks. A committee of outside advisers to the - By ANDREW POLLACK

QNEXA: FDA Panel Recommends Approval for Weight-Loss Drug

A previously rejected weight loss pill won an overwhelming endorsement from public health advisers Wednesday, raising hopes that the drug from Vivus Inc. could become the first new anti-obesity medication to reach the U.S. market in more than a ...

CORRECTED-UPDATE 1-Vivus obesity drug has safety risks-US FDA staff

Feb 17 (Reuters) - Vivus Incs obesity drug Qnexa helped people lose weight but may cause long-term health problems in overweight and obese patients, U.S. drugs reviewers said. Food and Drug Administration staff will ask an advisory panel to ...

FDA panel overwhelmingly backs previously rejected anti-obesity pill QNEXA

SILVER SPRING, Md. (AP) — A previously rejected weight loss pill won an overwhelming endorsement from public health advisers Wednesday, raising hopes that the drug from Vivus Inc. could become the first new anti-obesity medication to reach the ...

Phentermine/topiramate - Wikipedia, the free encyclopedia

The combination of the drugs phentermine and topiramate (trade name Qnexa) is an investigational medication for the treatment of obesity and related conditions such ...

QNEXA® - New Prescription Diet Pill

Qnexa is a possible new prescription diet pill that is showing remarkable weight loss properties in clinical testing. Its fate rests in the FDAs decision on acceptance.

FDA weighs fate of QNEXA for weight loss, again - ABC 33/40 ...

ABC 33/40 - Birmingham News, Weather, SportsFDA weighs fate of Qnexa for weight loss, again

QNEXA Still Raises Safety Concerns for FDA | ThirdAge

Federal health officials say they still have safety concerns about Qnexa, an experimental diet pill from drugmaker Vivus Inc., as the company prepares to ...

STOCKS AND BONDS; Light Trading Ahead of Earnings Season

A light trading day on Wall Street closed with slight gains for major stock indexes. With oil prices reaching a 30-month high of $108 a barrel, some investors are waiting for Alcoa to report its first-quarter earnings next Monday, the unofficial start of the earnings season, before making any big moves. Traders are hoping to see how rising gasoline - By THE ASSOCIATED PRESS

Diet Treatment, Already in Use, to Get F.D.A. Review

LOS OSOS, Calif. — Next week, advisers to the Food and Drug Administration will recommend whether the agency should approve the first new prescription diet pill in 13 years. The F.D.A. rejected the drug under review, Qnexa, in 2010, amid safety concerns, and the drug’s manufacturer is now presenting additional data to argue its case. - By ANDREW POLLACK

FDA Weighs Fate of QNEXA for Weight Loss, Again - Drugs.com ...

The U.S. Food and Drug Administration plans to take a second look at the weight loss pill Qnexa on Wednesday, after initially rejecting it because of concerns a.

FDA Weighs Fate of QNEXA for Weight Loss, Again - Yahoo! News

39 minutes ago ... From Yahoo! News: WEDNESDAY, Feb. 22 (HealthDay News) -- The U.S. Food and Drug Administration plans to take a second look at the ...

New weight-loss drug QNEXA to get second look by FDA today ...

16 hours ago ... The manufacturer says new data shows significant weight loss and improved heart health in obese patients.

Diet pill aims for US regulatory approval

Two years ago the US Food and Drug Administration rejected Qnexa because it raises risks of heart complications and possible damage to fetuses in pregnant women. Vivus of Mountain View, California, which makes the drug, argues that given the current ...

The Next Big Diet Pill? FDA Reconsiders Approval Of ‘QNEXA ...

A Food and Drug Administration panel is reconsidering whether to approve the diet pill Qnexa.

FDA AdComm recommends approval of QNEXA | theheart.org

Specifically, the panel voted 20 to 2 in favor of approving Qnexa, this despite protracted discussion about the potential adverse effect of the drug on heart rate and concerns over a risk of birth defects in mothers taking the ...

Diet Drug QNEXA Being Reconsidered

Frankel said she is now a “6 or 8 depending. And before surgery I was a 20, 22.” While she’s thrilled with the results, Frankel wishes a simple pill for obesity were available. “Oh, definitely that would have been easier," she said.

QNEXA® Obesity Drug Information and News

Qnexa is a trial medication being tested to treat obesity and showing some positive results.

Vivus Inc. (VVUS) FDA Approval 2012 - QNEXA® - Stocks To Buy ...

Vivus Inc. (VVUS) stock has been steadily rising as we head into 2012 due to the fact that the company will be seeking FDA Approval for Qnexa. Vivus Inc. (VVUS…

New Diet Pill QNEXA Awaits FDA Approval: 3 Things To Know

Qnexa, a new diet pill, will be the first new diet pill in 13 years if it gets approved by the Food and Drug Administration (FDA). The drug was previously rejected by the FDA in 2010 due to concerns of safety. Qnexa manufacturers are now ...

FDA advisors endorse weight-loss drug QNEXA

A panel of medical experts voted overwhelmingly Wednesday to endorse the controversial weight-loss drug Qnexa, clearing the way for the Food and Drug Administration to approve a new prescription obesity medication for the first time since 1999.

BEWARE OF . . .| OCT. 24-30

THE NEWS Two packages containing explosive devices shipped from Yemen and bound for synagogues in Chicago were intercepted in Britain and Dubai, setting off a global terror alert Friday that included searching other planes. BEHIND THE NEWS The explosives were packed in toner cartridges for computer printers. Speaking at the White House late Friday

About the new obesity drug, QNEXA. What type of drug is it?

I cant find what it actually does online. Is it an appetite suppressant, hunger suppressant, or a burner (like ephedra)? Or is it like Alli (where you crap a % of the fat you eat)?
Category: Medicine

Phentermine/topiramate - Wikipedia, the free encyclopedia

Qnexa is currently not approved for use in the United States. It was rejected by regulators in the United States Food and Drug Administration after a panel found ...

Panel to ponder fate of QNEXA weight loss pill | www.wftv.com

Once rejected by the FDA over safety concerns, the weight loss pill Qnexa on Wednesday will get a second chance before an FDA advisory committee.

FDA Panel Recommends Approval of Diet Drug QNEXA - ABC News

6 hours ago ... A U.S. Food and Drug Administration Advisory Committee today recommended approval of the weight loss drug Qnexa, a treatment many hope ...

Diet drug QNEXA will get a second look - latimes.com

Diet drugs have failed to impress government health regulators in recent years with several prospective medications being denied approval and another drug ...

Diet drug QNEXA comes with increased heart risks

UNDATED (CBS) -- A Food and Drug Administration panel is holding a new hearing on the weight loss pill Qxena. Research has shown the drug is effective at reducing weight, but health advisers denied approval in 2010 because of its potential side effects ...

Weight Loss Drug QNEXA - ABC News - ABCNews.com: Daily News ...

The FDA rejected an application from drug maker Vivus to have Qnexa approved for the treatment of obesity, citing possible health risks. But the results of a phase 3 ...

FDA: Vivus Weight Loss Drug Effective But Has Safety Concerns

WASHINGTON -(Dow Jones)- The Food and Drug Administration said Vivus Inc.s (VVUS) obesity drug Qnexa was effective at helping people lose weight but raised concerns about possible long-term side effects such as birth defects and an unknown ...

Vivus: FDA Panel Live Blog

A panel of outside experts impaneled by the U.S. Food and Drug Administration gathers today to review and pass judgment on Vivus (Symbol : VVUS) experimental obesity pill Qnexa. Once again, Qnexas safety will be the most hotly debated topic. At Vivus ...

FDA Weighs Fate of QNEXA for Weight Loss, Again - Health News ...

21 (HealthDay News) -- The U.S. Food and Drug Administration plans to take a second look at the weight loss pill Qnexa on Wednesday, after initially rejecting it because of concerns about heart problems and possible birth ...

BUSINESS BRIEFING | MEDICINE; Diet Drug Optimism Lifts Shares of Vivus

Shares of Vivus, a drug manufacturer, rose 26 percent as investors bet it would be able to convince regulators to approve its experimental weight loss drug, Qnexa. This week, the Food and Drug Administration told Vivus in a letter that it required additional information about the drugs safety before it could be approved. The F.D.A. did not, - By REUTERS

At QNEXA hearing, public commenters are split on the drugs value

Qnexa, an investigational drug to promote weight loss, has divided public health advocates, based on comments made Wednesday at a Food and Drug Administration advisory committee hearing. The advisory committee will vote later Wednesday in Silver ...

QNEXA® Obesity Drug Information and News

Qnexa is a trial medication being tested to treat obesity and showing some positive results.

FDA gives second look to controversial diet pill QNEXA

NEW YORK—It’s been 13 years since the Food and Drug Administration approved a prescription diet pill. On Wednesday, it takes a second look at a drug called Qnexa, a combination of the drugs phentermine, a stimulant, and topiramate, a seizure ...

With Safety Concerns Growing, F.D.A. Rejects Another Diet Pill

The Food and Drug Administration rejected another new diet pill on Thursday, the latest setback in the quest to develop treatments for overweight Americans amid the nations obesity epidemic. The rejected drug, called Qnexa, is the third weight loss medicine to run into trouble this month because of concerns about safety. Last week, the F.D.A. - Food and Drug Administration rejects new diet pill Qnexa, latest setback in quest to develop treatments for overweight Americans amid nations obesity epidemic; Qnexa is third weight loss medicine to run into trouble this month because of safety concerns; FDA declined to approve lorcaserin and also forced withdrawal of Meridia from market after 13 years; Vivus, developer of Qnexa, says it is confident it can provide FDA with thorough evaluation of drugs potential for causing heart and other problems, satisfying agency so that drug may win approval next year; photo (M) - By ANDREW POLLACK

Panel to Ponder Fate of QNEXA Weight-Loss Pill

Agreeing with an earlier advisory panel, the FDA in 2010 rejected the Qnexa weight loss pill over safety concerns. Now another panel will consider whether new safety data should make FDA change its mind.

QNEXA Obesity Drug - FDA Concerned About Long-term Side Effects

The FDA has expressed concerned regarding obesity drug Qnexa - a combination of phentermine and topiramate - and what associations there may be between ...

F.D.A. Panel Backs Drug to Treat Obesity

A federal advisory committee on Tuesday recommended approval of what could become the first new prescription diet pill in more than a decade. The advisory committee to the Food and Drug Administration voted 13 to 7 that the benefits of the drug, Contrave, outweighed its risks. The drug was developed by Orexigen Therapeutics of San Diego. The vote - Federal advisory committee to Food and Drug Administration recommends approval of Contrave, which could be first new drug to combat obesity in more than a decade and first marketed product for drug maker Orexgigen; same committee has recently voted against approval of two other weight-loss drugs, Qnexa and Lorcaserin, citing safety issues; following removal of drug Meridia from shelves in October, only one little-used prescription drug, Xenical, is currently available for long-term use in weight loss; photo (M) - By ANDREW POLLACK

QNEXA: A magic diet pill? | MNN - Mother Nature Network

Some consider Qnexa a silver bullet in the battle of the bugle — a once-a-day pill that melts away the pounds without all that bothersome exercise and healthy eating.

When will the diet pill QNEXA be approved by the FDA and be put on the market?

When will the diet pill Qnexa be approved by the FDA and be put on the market?
Answer: Not yet... "Food and Drug Administration (FDA) decided to reject Qnexa an experimental diet pill, which many suggested by experts in the last decade. drug manufacturers, Vivus Inc, said that the U.S. Food and Drug Administration (FDA) refused to approve the drug in its current form. The agency is requesting Vivus Inc to send more research study, including major cardiovascular events and risk for women of childbearing potential, and additional information about other health risks that may occur. vivus said, the FDA did not ask for new clinical studies, but it may be necessary if the agency concerns are not addressed."
Category: Diet & Fitness

OpEdNews - Article: Should the FDA Give Diet Drug QNEXA Another ...

Alli and Xenical encourage weight loss by blocking the bodys absorption of fat but can cause oily bowels and anal leakage. Comics had a lot of fun with them when ...

QNEXA Weight-Loss Drug Wins Advisory Panel’s Support

A federal advisory panel on Wednesday overwhelmingly recommended approval of what could become the first new prescription drug to treat obesity in 13 years. The advisory committee to the Food and Drug Administration voted 20 to 2 that the benefits from the weight loss provided by the drug, Qnexa, more than offset the potential risks of heart - By ANDREW POLLACK

New Diet Pill Fails to Win Approval

The Food and Drug Administration has declined to approve what would have been the first new prescription diet pill in more than a decade. The agencys rejection of the drug, called lorcaserin, was announced late Friday by the drugs developer, Arena Pharmaceuticals, and its marketing partner, Eisai. The rejection was not a surprise because an - By ANDREW POLLACK

VIVUS Announces FDA Acceptance of QNEXA New Drug Application ...

The target date for the FDA to complete its review of the Qnexa NDA is October ... "The FDA's acceptance of the Qnexa NDA marks an important milestone in the ...

FDA Weighs Fate of QNEXA for Weight Loss, Again - Yahoo! News

From Yahoo! News: TUESDAY, Feb. 21 (HealthDay News) -- The U.S. Food and Drug Administration plans to take a second look at the weight loss pill Qnexa on Wednesday ...

F.D.A. Fails To Approve Diet Drug

The Food and Drug Administration has declined to approve yet another prescription diet pill, vanquishing nearly any prospect that a new obesity medicine will be available to overweight Americans this year. In a rare move, the agency told the drug maker, Orexigen Therapeutics, that to win approval it must first do a long-term study to demonstrate - Orexigen Therapeutics fails to win Food and Drug Administration approval for prescription diet pill Contrave; FDA has rejected similar drugs, leaving overweight Americans without access to any new obesity medicines in 2011; agency is exercising considerable caution in assessing new generation of diet medicines after serious health problems, including deaths, caused by some older weight-loss pills; photo (M) - By ANDREW POLLACK

QNEXA Proponents Ask U.S. Experts To Back The Obesity Drug

Qnexa, which combines the appetite suppressant phentermine and anti-seizure drug topiramate, helped patients lose at least 10 percent of their weight after a year of treatment, the company said . Obesity, a leading cause of ...

is QNEXA available for purchase leagally any where in the world?

Answer: Qnexa® Qnexa®, produced by Vivus Inc, is a medication being studied for the treatment of obesity. Qnexa is an appetite suppressant and is a blend of two separate already existing medications Phentermine and Topiramate (brand name Topamax®). Phentermine has been approved by the FDA and has been used for many years as a very successful weight loss formula. Topiramate is a medication that has also been approved by the FDA and has been used for years as an anticonvulsant to treat epilepsy and has also been used to treat migraine headaches or as an antidepressant. However, it is the combination that is being tested and the results are promising. It is believed that Qnexa will greater reduce appetite and increase weight loss than Phentermine or Topiramate alone as well as show that it is a safer drug than either one substance by itself. Studies have shown that Qnexa has attained a larger weight loss compared to the placebo as well as compared to each of the two combined drugs individually. The FDA requires that in order for an obesity drug to be considered effective it must show that at least a third of the test patients lose at least 5% of their body weight. Qnexa passed this better than most. ================== I hope this is helpful.
Category: Geography

Should the FDA Give Diet Drug QNEXA Another Chance? « SpeakEasy

Should the FDA Give Diet Drug Qnexa Another Chance? Posted by Martha Rosenberg on @ 3:17 pm. Article printed from speakeasy: http://blogs.alternet.org/speakeasy. URL to article: ...

QNEXA® - New Prescription Diet Pill

Qnexa is a possible new prescription diet pill that is showing remarkable weight loss properties in clinical testing. Its fate rests in the FDA's decision on ...

Obesity

Qnexa® (phentermine and topiramate) Extended-release Capsules is an investigational, once-per-day, weight-loss therapy that combines low doses of two agents approved by ...

Whither QNEXA? A Brief History of Diet Pills and the FDA ...

Will the second time will be the charm for the diet drug Qnexa? The Food and Drug Administration (FDA) is reviewing the data on the weight-loss medication ...

A new weight loss drug – QNEXA – good news? or health nightmare ...

Read below…but also answer this question: is obesity a health crisis? Advisory Panel Backs Approval for Weight-Loss Drug By ANDREW POLLACK A federal advisory panel on Wednesday overwhelmingly recommended ...

Vivus Weight-Loss Pill Qnexa Wins Backing of FDA Panel: 22 (Bloomberg) -- Vivus Inc.s weight-loss pill Qnexa wo... http://t.co/sEPpvvid
From: AMCWellness - Source: twitterfeed

Vivus Weight-Loss Pill Qnexa Wins Backing of FDA Panel: 22 (Bloomberg) -- Vivus Inc.s weight-loss pill Qnexa wo... http://t.co/NirFfefx
From: ldaugthr3 - Source: twitterfeed

Qnexa Weight-Loss Drug Wins Advisory Panels Support http://t.co/BOmaQ4mo
From: WeightLossArt - Source: twitterfeed

Vivus Weight-Loss Pill Qnexa Wins Backing of FDA Panel: 22 (Bloomberg) -- Vivus Inc.s weight-loss pill Qnexa wo... http://t.co/liqNjoHG
From: JanetEveridge - Source: twitterfeed

Vivus Weight-Loss Pill Qnexa Wins Backing of FDA Panel: 22 (Bloomberg) -- Vivus Inc.s weight-loss pill Qnexa wo... http://t.co/Q6IC6ALB
From: weightIlost - Source: twitterfeed

NBC Nightly News with Brian Williams - FDA Panel Backs Diet Pill Qnexa: The advisory panel said the effectiveness of the drug, made b...
From: LucendaLloyd - Source: twitterfeed

If Qnexa gets the green light, who would get the drug?: But the drug increases the risk of cleft lip in babies w... http://t.co/nHZFabXN
From: EcoPregnancy - Source: twitterfeed

Weight loss pill Qnexa wins support of FDA panel http://t.co/3jIx4MPy
From: ScotNetwork - Source: HootSuite

Vivus Weight-Loss Pill Qnexa Wins Backing of FDA Panel http://t.co/ITcYwgT1
From: ScotNetwork - Source: HootSuite

Health Tips: FDA Panel Votes in Favor of Weight Loss Pill Qnexa http://t.co/xlU1KA4I
From: GSSpine - Source: HootSuite

Health Tips: FDA Panel Votes in Favor of Weight Loss Pill Qnexa http://t.co/R2gKafeo
From: TR_HealthSource - Source: HootSuite

Health Tips: FDA Panel Votes in Favor of Weight Loss Pill Qnexa http://t.co/ZvblpWu2
From: NJ_Chronic_Pain - Source: HootSuite

Health Tips: FDA Panel Votes in Favor of Weight Loss Pill Qnexa http://t.co/AQESRRWi
From: PlanetEarthX - Source: HootSuite

FDA Advisors Endorse Weight Loss Drug #Qnexa http://t.co/JYhgh46S #worldnews #evelynlozada #ghostrider2
From: uslivepost5 - Source: Google

News: Qnexa Weight-Loss Drug Wins Advisory Panel’s Suppor FDA: http://t.co/vDfD9lCW
From: pyramidmedicine - Source: Tweet Button